Any feedback?
Literature summary for 3.5.1.5 extracted from
- Production and characterization of a camelid single domain antibody-urease enzyme conjugate for the treatment of cancer (2015), Bioconjug. Chem., 26, 1144-1155 .
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | a novel immunoconjugate (L-DOS47) is developed and characterized as a therapeutic agent for tumors expressing CEACAM6. The single domain antibody AFAIKL2, which targets CEACAM6, is expressed in the Escherichia coli BL21 (DE3) pT7-7 system. High purity urease is extracted and purified from Jack bean meal. AFAIKL2 is activated using N-succinimidyl [4-iodoacetyl]aminobenzoate (SIAB) as the cross-linker and then conjugated to urease. The specificity and cytotoxicity of L-DOS47 is confirmed by screening in four cell lines (BxPC-3, A549, MCF7, and CEACAM6-transfected H23). BxPC-3, a CEACAM6-expressing cell line is most susceptible to L-DOS47. L-DOS47 is a potential therapeutic agent in human phase I clinical studies for nonsmall cell lung cancer | Canavalia ensiformis |
Cloned(Commentary)
| Cloned (Comment) | Organism |
|---|---|
| expression in the Escherichia coli BL21 (DE3) pT7-7 system | Canavalia ensiformis |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Canavalia ensiformis | P07374 | - |
- |
Purification (Commentary)
| Purification (Comment) | Organism |
|---|---|
- |
Canavalia ensiformis |
Subunits
| Subunits | Comment | Organism |
|---|---|---|
| hexamer | 6 * 91000 | Canavalia ensiformis |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
